Global Antibacterial Drugs Market to Reach USD 36 Bn to 2022, Forecasts GBI Research in Its New Report Available at MarketPublishers.com
20 Feb 2017 • by Natalie Aster
LONDON – At present, concerns over antimicrobial resistance are on the rise and its progressive growth drive the need for innovation in the world’s market for antibacterial drugs marketplace.
Vaccines represent the most common type of drugs used to prevent bacterial infections. Yet, some manufacturers are developing several prophylactic monoclonal antibodies at the moment.
The situation is hardly different when it comes to the treatment of bacterial infections. Beta-lactam antibiotics are the most common type of such drugs. These antibiotics include penicillin. Given the resistance to it that many bacteria have, these drugs are becoming increasingly ineffective. So, beta-lactams available nowadays often represent a combination of a beta-lactamase inhibitor and drugs of a beta-lactam.
There are also some other classes of drugs that are used to treat bacterial infections: fluoroquinolones, protein synthesis inhibitors, etc. Here is one more challenge: bacterial resistance developed against these drugs, as well.
Currently, vaccines dominate the vaccine marketplace, and those that are aimed at the preventing diphtheria, pneumococcal infections, pertussis and tetanus.
As of 2015, the market for antibacterial drugs valued slightly over USD 27 billion. It is set to be worth approximately USD 36 billion in 2022.
In-demand research report “Global Antibacterial Drugs Market to 2022” worked out by GBI Research offers a comprehensive discussion of the worldwide market for antibacterial resistance drugs marketplace. The study provides a 360-degree overview of the market.
It reviews major marketed products. The report assesses the pipeline landscape and estimates the overall market size. The research study focuses on the performance of the marketplace.
It scrutinizes the competitive landscape. The research report analyzes major companies and sheds light on their positioning. The study limelights strategic consolidations, too. Future outlook through 2022 for this marketplace is also available in the report.
More insightful reports by GBI Research can be found at its page.